Combinatorial CRISPR screen identifies fitness effects of gene paralogues
Nicola Thompson(Wellcome Sanger Institute), David J. Adams(Wellcome Sanger Institute), Martin Del Castillo Velasco‐Herrera(Wellcome Sanger Institute), Louise van der Weyden(Wellcome Sanger Institute), Marco Ranzani(Wellcome Sanger Institute), Victoria Offord(Wellcome Sanger Institute), Fiona M. Behan(Age UK), Guido Zagnoli-Vieira(The Gurdon Institute), Beiyuan Fu(Wellcome Sanger Institute), Anneliese O. Speak(University of Cambridge), Stephen P. Jackson(University of Cambridge), James Hewinson(Wellcome Sanger Institute), Emanuel Gonçalves(European Bioinformatics Institute), Vivek Iyer(Wellcome Sanger Institute), Victoria Harle(Wellcome Sanger Institute), Alastair Droop(Wellcome Sanger Institute), Francesco Iorio(Human Technopole), Mathew J. Garnett(Wellcome Sanger Institute), Elizabeth Anderson(Wellcome Sanger Institute), Fengtang Yang(Shandong University of Technology), Phil Chapman(Cancer Research UK Manchester Institute), Holly Robertson(Wellcome Sanger Institute)
Cited by 136
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k